Targeting c-FOS and DUSP1 abrogates intrinsic resistance to tyrosine-kinase inhibitor therapy in BCR-ABL-induced leukemia
靶向 c-FOS 和 DUSP1 可消除 BCR-ABL 诱发的白血病对酪氨酸激酶抑制剂治疗的内在耐药性
期刊:Nature Medicine
影响因子:58.7
doi:10.1038/nm.4310
Meenu Kesarwani, Zachary Kincaid, Ahmed Gomaa, Erika Huber, Sara Rohrabaugh, Zain Siddiqui, Muhammad F Bouso, Tahir Latif, Ming Xu, Kakajan Komurov, James C Mulloy, Jose A Cancelas, H Leighton Grimes, Mohammad Azam
